Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
about
Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and OutcomesEstimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural UgandaAssessing the burden of medical impoverishment by cause: a systematic breakdown by disease in Ethiopia.Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis.Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural MalawiCosts of HIV/AIDS treatment in Indonesia by time of treatment and stage of diseaseThe HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa.Alternative financing mechanisms for ART programs in health facilities in Uganda: a mixed-methods approach.Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study.Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.Cost-Effectiveness and Quality of Care of a Comprehensive ART Program in Malawi.Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa.Sustainable HIV treatment in Africa through viral-load-informed differentiated care.Annual cost of antiretroviral therapy among three service delivery models in Uganda.Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness.Using Top-down and Bottom-up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at ScaleModeling the Cost-Effectiveness of Home-Based HIV Testing and Education (HOPE) for Pregnant Women and Their Male Partners in Nyanza Province, Kenya.The costs of HIV treatment and care in Ghana: A longitudinal multi-site analysis.Multi-month prescriptions, fast-track refills, and community ART groups: results from a process evaluation in Malawi on using differentiated models of care to achieve national HIV treatment goals.Economic Costs and Health-Related Quality of Life Outcomes of HIV Treatment After Self- and Facility-Based HIV Testing in a Cluster Randomized Trial.Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile.Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan AfricaAdherence clubs for long-term provision of antiretroviral therapy: cost-effectiveness and access analysis from Khayelitsha, South Africa.Cost analysis of two community-based HIV testing service modalities led by a Non-Governmental Organization in Cape Town, South Africa.Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya.Transitioning financial responsibility for health programs from external donors to developing countries: Key issues and recommendations for policy and research.Quantifying and reducing statistical uncertainty in sample-based health program costing studies in low- and middle-income countries.Explaining the heterogeneity in average costs per HIV/AIDS patient in Nigeria: The role of supply-side and service delivery characteristics.Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study.Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: A prospective hospital cohort study in Malawi.Optimal timing of HIV home-based counselling and testing rounds in Western Kenya.Understanding the dynamic interactions driving the sustainability of ART scale-up implementation in UgandaThe emerging health impact of voluntary medical male circumcision in Zimbabwe: An evaluation using three epidemiological modelsEfficiency of HIV services in Nigeria: Determinants of unit cost variation of HIV counseling and testing and prevention of mother-to-child transmission interventionsHIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing?Decreasing cost of public sector first-line ART services in India from 2007-2008 to 2015-2016
P2860
Q28081319-1196A741-ECD8-41CC-86D5-BD876218F6A3Q28551309-2B0966CB-7040-4B57-939F-EC57F9E4B217Q30380850-1DA010EC-B5AD-4142-8912-AE0AFC10D7DBQ35262551-23C46E16-FB53-4882-A2C9-3BE8EBFB8440Q35668862-700AF9A3-CE4D-4775-8A59-F1B76FB74C11Q35794458-7C423133-E98B-4460-976E-08A188A8D76BQ35850530-CED4F573-7A6E-4FE8-BFE7-4BA1002F7D57Q36224801-973C8C44-66F5-429E-B5A2-C5088F775A0CQ36257996-3A880239-68BA-4EDB-A919-4B5A06F0BFC0Q36670480-24332BA1-A119-42FF-A93D-5166186B2E55Q36915084-37B364AC-41FD-43E7-82FF-359563542377Q36992861-FC1B7F7E-D99D-466C-9907-68D99241527DQ37003072-D491BE59-4965-44FC-9922-D4A538AA2479Q37064741-28A2025A-324C-499E-B40C-AEC9A7C6F6E2Q37116573-6172D62C-F078-4792-B441-48E68E855701Q37244536-5BFA8379-5E76-4D90-A95A-8303A31BE1F2Q37343926-CAC63A7A-157B-4CCD-866F-293E787CFD90Q37420094-3C702EC6-4C40-4D58-906A-EE07D2157599Q38625932-BA04554C-44B7-497D-9CF1-DF4209FE8A7FQ38645065-B05B2143-5C80-4071-B2DC-1FEA29F9A1BDQ39204173-98BD6E77-492F-41C4-8A57-A6D6B6BCBE78Q39353931-91972B2D-9F47-4F3F-AC4E-02FDC6191D3AQ40491916-92D6EE01-DAAE-44EB-A34D-057005D5775BQ40701983-08D1F236-CE60-4F36-99F5-484A2E363178Q47134298-DE0841A9-8F0D-495D-A717-7F6531527355Q47601085-028116FC-0F9C-40B2-9E9C-90F0455E9B16Q49386592-0E91246E-0FBD-49D2-A681-656AE87F5805Q52325651-D79268E9-C8E4-4847-BD95-2599ABBBC258Q53687071-864B93AD-1665-4F46-9384-4A98E72C23C5Q54233736-90FB4438-B7B7-42C9-871A-FF283C85C8CBQ54255388-C9031C37-BBD8-4908-9365-B880436146E8Q55362954-35CBF02B-EDF9-4CB6-92D0-6B76B5D1A8C0Q56516479-B174E9FC-1146-4B1E-9320-900856443F18Q57175542-856A385A-E59F-4D3D-A86B-D888865BAE17Q58592720-4E8BEDA7-5372-4B97-8A51-4FAE25AB2159Q58696725-580E6AEE-89A7-4D28-AB0D-3328DE3BD9B9Q59129825-CD3EABA4-A710-4338-81C6-A93403E8A591
P2860
Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Multi-country analysis of trea ...... anda, South Africa and Zambia.
@ast
Multi-country analysis of trea ...... anda, South Africa and Zambia.
@en
Multi-country analysis of trea ...... anda, South Africa and Zambia.
@nl
type
label
Multi-country analysis of trea ...... anda, South Africa and Zambia.
@ast
Multi-country analysis of trea ...... anda, South Africa and Zambia.
@en
Multi-country analysis of trea ...... anda, South Africa and Zambia.
@nl
prefLabel
Multi-country analysis of trea ...... anda, South Africa and Zambia.
@ast
Multi-country analysis of trea ...... anda, South Africa and Zambia.
@en
Multi-country analysis of trea ...... anda, South Africa and Zambia.
@nl
P2093
P2860
P921
P1433
P1476
Multi-country analysis of trea ...... anda, South Africa and Zambia.
@en
P2093
Ben Chilima
Blackson Matatiyo
Bona Mukosha Chitah
Crispin Moyo
Dan Gwinnell
Elya Tagar
Frank Chimbwandira
Jean Pierre Nyemazi
Kate Condliffe
Lauren Shear
P2860
P304
P356
10.1371/JOURNAL.PONE.0108304
P407
P577
2014-11-12T00:00:00Z